MARINA BIOTECH INC COM STK (DE)
MRNA
MRNA was delisted on the 1st of February, 2012.
2 hedge funds and large institutions have $45K invested in MARINA BIOTECH INC COM STK (DE) in 2021 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
15% more capital invested
Capital invested by funds: $39K → $45K (+$6K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
-$4.1K |
MRNA Hedge Fund Activity: Q1 2021 in Review
2 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q1 2021, worth a combined $45K — up 15% from $39K a quarter earlier.
Fund positioning in MRNA was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Sonora Investment Management, cutting an estimated $4.1K.
- 2 institutional investors held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $45K of MARINA BIOTECH INC COM STK (DE) stock for Q1 2021, up 15% quarter-over-quarter.
- 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q1 2021 and 0 closed out.
- The largest MARINA BIOTECH INC COM STK (DE) seller in Q1 2021 was Sonora Investment Management, an estimated $4.1K sold.
Based on aggregated 13F filings for Q1 2021.